vs
PARK OHIO HOLDINGS CORP（PKOH）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是PARK OHIO HOLDINGS CORP的2.0倍（$772.1M vs $395.0M），Revvity净利率更高（12.7% vs 0.3%，领先12.5%），Revvity同比增速更快（5.9% vs 1.7%），Revvity自由现金流更多（$161.8M vs $36.0M），过去两年Revvity的营收复合增速更高（9.0% vs -2.7%）
帕克俄亥俄控股集团旗下核心银行为帕克国民银行，集团资产规模达99亿美元，业务覆盖俄亥俄州、肯塔基州北部以及南北卡罗来纳地区。帕克国民银行旗下拥有三家金融关联机构，分别为 Guardian 金融公司、Scope 飞机租赁公司以及 SE 地产控股有限公司，总部坐落于俄亥俄州纽瓦克市。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
PKOH vs RVTY — 直观对比
营收规模更大
RVTY
是对方的2.0倍
$395.0M
营收增速更快
RVTY
高出4.2%
1.7%
净利率更高
RVTY
高出12.5%
0.3%
自由现金流更多
RVTY
多$125.8M
$36.0M
两年增速更快
RVTY
近两年复合增速
-2.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $395.0M | $772.1M |
| 净利润 | $1.0M | $98.4M |
| 毛利率 | 17.3% | — |
| 营业利润率 | 2.5% | 14.5% |
| 净利率 | 0.3% | 12.7% |
| 营收同比 | 1.7% | 5.9% |
| 净利润同比 | 100.0% | 3.9% |
| 每股收益（稀释后） | $0.06 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PKOHRVTY
| Q4 25 | $395.0M | $772.1M | ||
| Q3 25 | $398.6M | $698.9M | ||
| Q2 25 | $400.1M | $720.3M | ||
| Q1 25 | $405.4M | $664.8M | ||
| Q4 24 | $388.4M | $729.4M | ||
| Q3 24 | $417.6M | $684.0M | ||
| Q2 24 | $432.6M | $691.7M | ||
| Q1 24 | $417.6M | $649.9M |
净利润PKOHRVTY
| Q4 25 | $1.0M | $98.4M | ||
| Q3 25 | $5.3M | $46.7M | ||
| Q2 25 | $9.2M | $53.9M | ||
| Q1 25 | $8.3M | $42.2M | ||
| Q4 24 | $500.0K | $94.6M | ||
| Q3 24 | $9.8M | $94.4M | ||
| Q2 24 | $11.9M | $55.4M | ||
| Q1 24 | $9.6M | $26.0M |
毛利率PKOHRVTY
| Q4 25 | 17.3% | — | ||
| Q3 25 | 16.7% | 53.6% | ||
| Q2 25 | 17.0% | 54.5% | ||
| Q1 25 | 16.8% | 56.5% | ||
| Q4 24 | 16.6% | — | ||
| Q3 24 | 17.3% | 56.3% | ||
| Q2 24 | 16.9% | 55.7% | ||
| Q1 24 | 17.1% | 54.6% |
营业利润率PKOHRVTY
| Q4 25 | 2.5% | 14.5% | ||
| Q3 25 | 4.3% | 11.7% | ||
| Q2 25 | 5.0% | 12.6% | ||
| Q1 25 | 4.7% | 10.9% | ||
| Q4 24 | 3.7% | 16.3% | ||
| Q3 24 | 5.7% | 14.3% | ||
| Q2 24 | 5.7% | 12.4% | ||
| Q1 24 | 5.7% | 6.8% |
净利率PKOHRVTY
| Q4 25 | 0.3% | 12.7% | ||
| Q3 25 | 1.3% | 6.7% | ||
| Q2 25 | 2.3% | 7.5% | ||
| Q1 25 | 2.0% | 6.4% | ||
| Q4 24 | 0.1% | 13.0% | ||
| Q3 24 | 2.3% | 13.8% | ||
| Q2 24 | 2.8% | 8.0% | ||
| Q1 24 | 2.3% | 4.0% |
每股收益（稀释后）PKOHRVTY
| Q4 25 | $0.06 | $0.86 | ||
| Q3 25 | $0.38 | $0.40 | ||
| Q2 25 | $0.66 | $0.46 | ||
| Q1 25 | $0.60 | $0.35 | ||
| Q4 24 | $0.00 | $0.77 | ||
| Q3 24 | $0.73 | $0.77 | ||
| Q2 24 | $0.92 | $0.45 | ||
| Q1 24 | $0.75 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $44.8M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $380.9M | $7.3B |
| 总资产 | $1.4B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PKOHRVTY
| Q4 25 | $44.8M | $919.9M | ||
| Q3 25 | $50.8M | $931.4M | ||
| Q2 25 | $45.6M | $991.8M | ||
| Q1 25 | $54.5M | $1.1B | ||
| Q4 24 | $53.1M | $1.2B | ||
| Q3 24 | $59.5M | $1.2B | ||
| Q2 24 | $59.9M | $2.0B | ||
| Q1 24 | $61.6M | $1.7B |
股东权益PKOHRVTY
| Q4 25 | $380.9M | $7.3B | ||
| Q3 25 | $374.8M | $7.4B | ||
| Q2 25 | $371.1M | $7.6B | ||
| Q1 25 | $349.2M | $7.6B | ||
| Q4 24 | $330.8M | $7.7B | ||
| Q3 24 | $335.9M | $7.9B | ||
| Q2 24 | $293.8M | $7.9B | ||
| Q1 24 | $288.5M | $7.8B |
总资产PKOHRVTY
| Q4 25 | $1.4B | $12.2B | ||
| Q3 25 | $1.4B | $12.1B | ||
| Q2 25 | $1.4B | $12.4B | ||
| Q1 25 | $1.4B | $12.4B | ||
| Q4 24 | $1.4B | $12.4B | ||
| Q3 24 | $1.4B | $12.8B | ||
| Q2 24 | $1.4B | $13.4B | ||
| Q1 24 | $1.4B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $48.7M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $161.8M |
| 自由现金流率自由现金流/营收 | 9.1% | 21.0% |
| 资本支出强度资本支出/营收 | 3.2% | 2.6% |
| 现金转化率经营现金流/净利润 | 48.70× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $2.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流PKOHRVTY
| Q4 25 | $48.7M | $182.0M | ||
| Q3 25 | $17.3M | $138.5M | ||
| Q2 25 | $-13.7M | $134.3M | ||
| Q1 25 | $-10.0M | $128.2M | ||
| Q4 24 | $26.4M | $174.2M | ||
| Q3 24 | $9.0M | $147.9M | ||
| Q2 24 | $-2.7M | $158.6M | ||
| Q1 24 | $2.3M | $147.6M |
自由现金流PKOHRVTY
| Q4 25 | $36.0M | $161.8M | ||
| Q3 25 | $6.6M | $120.0M | ||
| Q2 25 | $-21.1M | $115.5M | ||
| Q1 25 | $-19.5M | $112.2M | ||
| Q4 24 | $17.3M | $149.8M | ||
| Q3 24 | $-100.0K | $125.6M | ||
| Q2 24 | $-10.1M | $136.6M | ||
| Q1 24 | $-3.5M | $129.7M |
自由现金流率PKOHRVTY
| Q4 25 | 9.1% | 21.0% | ||
| Q3 25 | 1.7% | 17.2% | ||
| Q2 25 | -5.3% | 16.0% | ||
| Q1 25 | -4.8% | 16.9% | ||
| Q4 24 | 4.5% | 20.5% | ||
| Q3 24 | -0.0% | 18.4% | ||
| Q2 24 | -2.3% | 19.7% | ||
| Q1 24 | -0.8% | 20.0% |
资本支出强度PKOHRVTY
| Q4 25 | 3.2% | 2.6% | ||
| Q3 25 | 2.7% | 2.6% | ||
| Q2 25 | 1.8% | 2.6% | ||
| Q1 25 | 2.3% | 2.4% | ||
| Q4 24 | 2.3% | 3.4% | ||
| Q3 24 | 2.2% | 3.3% | ||
| Q2 24 | 1.7% | 3.2% | ||
| Q1 24 | 1.4% | 2.7% |
现金转化率PKOHRVTY
| Q4 25 | 48.70× | 1.85× | ||
| Q3 25 | 3.26× | 2.97× | ||
| Q2 25 | -1.49× | 2.49× | ||
| Q1 25 | -1.20× | 3.03× | ||
| Q4 24 | 52.80× | 1.84× | ||
| Q3 24 | 0.92× | 1.57× | ||
| Q2 24 | -0.23× | 2.87× | ||
| Q1 24 | 0.24× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PKOH
| Supply Technologies Product | $164.6M | 42% |
| Engineered Products | $116.3M | 29% |
| Fuel Rubber And Plastic Products | $91.6M | 23% |
| Engineered Specialty Products | $22.5M | 6% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
